Should you buy PTHS stock?
Last updated:
Based on market data through , StockInvest.us rates Channel Therapeutics Corporation (PTHS) as a Buy Candidate with a technical score of 1.25 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Down 1.53%
- 3-month trend forecast Up 2.96%
- Highly efficient cash conversion (101% FCF/OCF ratio)
- Trading above its 200-day moving average
- +52.6% price growth over the last year
Green day on Monday for Channel Therapeutics Corporation stock after gaining 2.26%
(Market data through Aug 10, 2026)
The Channel Therapeutics Corporation stock price gained 2.26% on the last trading day (Monday, 10th Aug 2026), rising from $28.36 to $29.00. During the last trading day the stock fluctuated 2.84% from a day low at $28.20 to a day high of $29.00. The price has risen in 6 of the last 10 days and is up by 5.11% over the past 2 weeks. Volume fell on the last day by -22 thousand shares and in total, 20 thousand shares were bought and sold for approximately $592.33 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $29.96 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 2.96% during the next 3 months and, with a 90% probability hold a price between $25.41 and $30.84 at the end of this 3-month period.
PTHS Signals & Forecast
The Channel Therapeutics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $28.22 and $27.38. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, August 06, 2026, and so far it has fallen -1.53%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Channel Therapeutics Corporation stock
Channel Therapeutics Corporation finds support from accumulated volume at $28.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.80 between high and low, or 2.84%. For the last week the stock has had daily average volatility of 5.59%.
Our recommended stop-loss: $27.86 (-3.93%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 2 days ago.)
Trading Expectations (PTHS) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Channel Therapeutics Corporation to open at $28.73, and during the day (based on 14 day Average True Range), to move between $28.01 and $29.99, which gives a possible trading interval of +/-$1.98 (+/-7.09%) up or down from last closing price. If Channel Therapeutics Corporation takes out the full calculated possible swing range there will be an estimated 7.09% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $29.21 (0.72%) than the support at $28.66 (1.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Channel Therapeutics Corporation stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Channel Therapeutics Corporation stock to perform well in the short-term.
Current score:
1.252
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $28.73 ( 0.92%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PTHS Performance
Trading levels for PTHS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.53 | 1.84% |
| R2 | 29.23 | 0.785% |
| R1 | 29.04 | 0.134% |
| Price | 29.00 | |
| S1 | 28.43 | -1.97% |
| S2 | 28.24 | -2.62% |
| S3 | 27.93 | -3.68% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.50 | 1.72% |
| R2 | 29.45 | 1.55% |
| R1 | 29.21 | 0.724% |
| Price | 29.00 | |
| S1 | 28.66 | -1.17% |
| S2 | 26.84 | -7.45% |
| S3 | 26.25 | -9.48% |
FAQ
Click here for our free guide on how to buy Channel Therapeutics Corporation Stock.
Buy PTHS